FMC Corporation to Sell Newark R&D Site for $114 Million

The transaction, expected to conclude in the fourth quarter of 2026, involves converting underutilized real estate into liquid capital. Executives stated that the proceeds will be directed toward debt reduction, a move designed to strengthen the company’s balance sheet. FMC will retain ownership of its adjacent properties in Maryland as part of the broader asset management strategy.

Seva Rostovtsev, executive vice president and chief technology officer, emphasized that the site will continue to serve as the central hub for the company's innovation pipeline. While the agreement is subject to a due diligence period and the finalization of leaseback terms, management maintains that the site's core scientific infrastructure and research capabilities will remain undisturbed. The deal remains preliminary, with both parties retaining the right to renegotiate terms before the final closing.